Outcomes following definitive treatment of malignant peripheral nerve sheath tumor are significantly worse for patients with neurofibromatosis type 1: A Canadian Sarcoma Research and Clinical Collaboration study. [PDF]
Aubrey RE +7 more
europepmc +1 more source
Correction: Phase I/II, open-label, multicenter study of durvalumab in combination with tremelimumab in pediatric patients with advanced solid tumors. [PDF]
Hargrave D +8 more
europepmc +1 more source
Neurofibromatosis type 1 with bladder neurofibroma followed by retroperitoneal malignant peripheral nerve sheath tumor: a case report. [PDF]
Ishii N +8 more
europepmc +1 more source
Breathless and Beyond: Anterior Mediastinal Malignant Peripheral Nerve Sheath Tumor as a Rare Neurofibromatosis Type 1 Manifestation. [PDF]
Raza MH +8 more
europepmc +1 more source
FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study. [PDF]
Reitsam NG +15 more
europepmc +1 more source
Prolonged Mitogen-Activated Protein Kinase Kinase (MEK) Inhibition Induces Increase in Proteolysis and Compensatory Phosphorylation of MEK and Protein Kinase B (AKT) in Plexiform Neurofibroma Cells. [PDF]
Ji K +3 more
europepmc +1 more source
Lithium carbonate-loaded polymeric nano-micelles for enhanced antitumor activity against NF1-associated malignant peripheral nerve sheath tumors <i>via</i> improved cellular uptake. [PDF]
Yang A +9 more
europepmc +1 more source
Primary Intraosseous Malignant Nerve Sheath Tumor Of Humerus Presenting With Pathological Fracture: A Rare Case Report With Review Of Literature. [PDF]
Jalan D +5 more
europepmc +1 more source

